Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 198

1.

Aerobic Training Protects Cardiac Function During Advancing Age: A Meta-Analysis of Four Decades of Controlled Studies.

Beaumont AJ, Grace FM, Richards JC, Campbell AK, Sculthorpe NF.

Sports Med. 2019 Feb;49(2):199-219. doi: 10.1007/s40279-018-1004-3. Review.

2.

Safety and efficacy of dacomitinib in korean patients with KRAS wild-type advanced non-small-cell lung cancer refractory to chemotherapy and erlotinib or gefitinib: a phase I/II trial.

Park K, Cho BC, Kim DW, Ahn MJ, Lee SY, Gernhardt D, Taylor I, Campbell AK, Zhang H, Giri N, Letrent SP, O'Connell J, Heo DS.

J Thorac Oncol. 2014 Oct;9(10):1523-31. doi: 10.1097/JTO.0000000000000275.

3.

An endogenous green fluorescent protein-photoprotein pair in Clytia hemisphaerica eggs shows co-targeting to mitochondria and efficient bioluminescence energy transfer.

Fourrage C, Swann K, Gonzalez Garcia JR, Campbell AK, Houliston E.

Open Biol. 2014 Apr 9;4:130206. doi: 10.1098/rsob.130206.

4.

A phase 2 trial of dacomitinib (PF-00299804), an oral, irreversible pan-HER (human epidermal growth factor receptor) inhibitor, in patients with advanced non-small cell lung cancer after failure of prior chemotherapy and erlotinib.

Reckamp KL, Giaccone G, Camidge DR, Gadgeel SM, Khuri FR, Engelman JA, Koczywas M, Rajan A, Campbell AK, Gernhardt D, Ruiz-Garcia A, Letrent S, Liang J, Taylor I, O'Connell JP, Jänne PA.

Cancer. 2014 Apr 15;120(8):1145-54. doi: 10.1002/cncr.28561. Epub 2014 Feb 5.

5.

Health-related quality of life in patients with advanced nonsquamous non-small-cell lung cancer receiving bevacizumab or bevacizumab-plus-pemetrexed maintenance therapy in AVAPERL (MO22089).

Rittmeyer A, Gorbunova V, Vikström A, Scherpereel A, Kim JH, Ahn MJ, Chella A, Chouaid C, Campbell AK, Barlesi F.

J Thorac Oncol. 2013 Nov;8(11):1409-16. doi: 10.1097/JTO.0b013e3182a46bcf.

6.

An observational study of cognitive function in patients with irritable bowel syndrome and inflammatory bowel disease.

Berrill JW, Gallacher J, Hood K, Green JT, Matthews SB, Campbell AK, Smith A.

Neurogastroenterol Motil. 2013 Nov;25(11):918-e704. doi: 10.1111/nmo.12219. Epub 2013 Aug 26.

PMID:
23981191
7.

Selectivity mechanism of the mechanosensitive channel MscS revealed by probing channel subconducting states.

Cox CD, Nomura T, Ziegler CS, Campbell AK, Wann KT, Martinac B.

Nat Commun. 2013;4:2137. doi: 10.1038/ncomms3137.

PMID:
23842527
8.

Symptoms of irritable bowel syndrome in patients with inflammatory bowel disease: examining the role of sub-clinical inflammation and the impact on clinical assessment of disease activity.

Berrill JW, Green JT, Hood K, Campbell AK.

Aliment Pharmacol Ther. 2013 Jul;38(1):44-51. doi: 10.1111/apt.12335. Epub 2013 May 13.

9.

Darwin shines light on the evolution of bioluminescence.

Campbell AK.

Luminescence. 2012 Nov-Dec;27(6):447-9. doi: 10.1002/bio.2429. Epub 2012 Sep 21. No abstract available.

PMID:
23001967
10.

Randomized phase II study of dacomitinib (PF-00299804), an irreversible pan-human epidermal growth factor receptor inhibitor, versus erlotinib in patients with advanced non-small-cell lung cancer.

Ramalingam SS, Blackhall F, Krzakowski M, Barrios CH, Park K, Bover I, Seog Heo D, Rosell R, Talbot DC, Frank R, Letrent SP, Ruiz-Garcia A, Taylor I, Liang JQ, Campbell AK, O'Connell J, Boyer M.

J Clin Oncol. 2012 Sep 20;30(27):3337-44. doi: 10.1200/JCO.2011.40.9433. Epub 2012 Jul 2.

11.

Enzymatic activity of albumin shown by coelenterazine chemiluminescence.

Vassel N, Cox CD, Naseem R, Morse V, Evans RT, Power RL, Brancale A, Wann KT, Campbell AK.

Luminescence. 2012 May-Jun;27(3):234-41. doi: 10.1002/bio.2357. Epub 2012 Feb 24.

PMID:
22362656
12.

Association of lactose sensitivity with inflammatory bowel disease--demonstrated by analysis of genetic polymorphism, breath gases and symptoms.

Eadala P, Matthews SB, Waud JP, Green JT, Campbell AK.

Aliment Pharmacol Ther. 2011 Oct;34(7):735-46. doi: 10.1111/j.1365-2036.2011.04799.x. Epub 2011 Aug 4.

13.

Bacterial metabolic 'toxins': a new mechanism for lactose and food intolerance, and irritable bowel syndrome.

Campbell AK, Matthews SB, Vassel N, Cox CD, Naseem R, Chaichi J, Holland IB, Green J, Wann KT.

Toxicology. 2010 Dec 30;278(3):268-76. doi: 10.1016/j.tox.2010.09.001. Epub 2010 Sep 18. Review.

PMID:
20851732
14.

The molecular basis of lactose intolerance.

Campbell AK, Waud JP, Matthews SB.

Sci Prog. 2009;92(Pt 3-4):241-87. Review.

PMID:
19960866
15.

A large-conductance (BK) potassium channel subtype affects both growth and mineralization of human osteoblasts.

Henney NC, Li B, Elford C, Reviriego P, Campbell AK, Wann KT, Evans BA.

Am J Physiol Cell Physiol. 2009 Dec;297(6):C1397-408. doi: 10.1152/ajpcell.00311.2009. Epub 2009 Sep 23.

16.

Inpatient care to community care: improving clinical handover in the private mental health setting.

Wood SK, Campbell AK, Marden JD, Schmidtman L, Blundell GH, Sheerin NJ, Davidson PM.

Med J Aust. 2009 Jun 1;190(11 Suppl):S144-9.

PMID:
19485865
17.

ATP regulates calcium efflux and growth in E. coli.

Naseem R, Wann KT, Holland IB, Campbell AK.

J Mol Biol. 2009 Aug 7;391(1):42-56. doi: 10.1016/j.jmb.2009.05.064. Epub 2009 May 27.

PMID:
19481094
18.

Quantifying the 'hidden' lactose in drugs used for the treatment of gastrointestinal conditions.

Eadala P, Waud JP, Matthews SB, Green JT, Campbell AK.

Aliment Pharmacol Ther. 2009 Mar 15;29(6):677-87. doi: 10.1111/j.1365-2036.2008.03889.x.

19.

Jean-Marie Bassot (1933-2007): a life of unquenched curiosity.

Campbell AK.

Luminescence. 2008 May-Jun;23(3):187-90. doi: 10.1002/bio.1048. No abstract available.

PMID:
18452142
20.

pH and monovalent cations regulate cytosolic free Ca(2+) in E. coli.

Naseem R, Holland IB, Jacq A, Wann KT, Campbell AK.

Biochim Biophys Acta. 2008 Jun;1778(6):1415-22. doi: 10.1016/j.bbamem.2008.02.006. Epub 2008 Feb 21.

21.

Measurement of breath hydrogen and methane, together with lactase genotype, defines the current best practice for investigation of lactose sensitivity.

Waud JP, Matthews SB, Campbell AK.

Ann Clin Biochem. 2008 Jan;45(Pt 1):50-8. doi: 10.1258/acb.2007.007147.

PMID:
18275674
22.

Methylglyoxal and other carbohydrate metabolites induce lanthanum-sensitive Ca2+ transients and inhibit growth in E. coli.

Campbell AK, Naseem R, Holland IB, Matthews SB, Wann KT.

Arch Biochem Biophys. 2007 Dec 1;468(1):107-13. Epub 2007 Sep 19.

PMID:
17961498
23.

Cytosolic Ca2+ regulates protein expression in E. coli through release from inclusion bodies.

Naseem R, Davies SR, Jones H, Wann KT, Holland IB, Campbell AK.

Biochem Biophys Res Commun. 2007 Aug 17;360(1):33-9. Epub 2007 Jun 14.

PMID:
17583677
24.

Fermentation product butane 2,3-diol induces Ca2+ transients in E. coli through activation of lanthanum-sensitive Ca2+ channels.

Campbell AK, Naseem R, Wann K, Holland IB, Matthews SB.

Cell Calcium. 2007 Feb;41(2):97-106. Epub 2006 Jul 13.

PMID:
16842848
25.

The molecular basis of lactose intolerance.

Campbell AK, Waud JP, Matthews SB.

Sci Prog. 2005;88(Pt 3):157-202. Review.

PMID:
16805112
26.

Darwin's illness revealed.

Campbell AK, Matthews SB.

Postgrad Med J. 2005 Apr;81(954):248-51.

27.

Low erythrocyte folate, but not plasma vitamin B-12 or homocysteine,is associated with dementia in elderly Latinos.

Campbell AK, Jagust WJ, Mungas DM, Miller JW, Green R, Haan MN, Allen LH.

J Nutr Health Aging. 2005;9(1):39-43.

PMID:
15750664
28.

Systemic lactose intolerance: a new perspective on an old problem.

Matthews SB, Waud JP, Roberts AG, Campbell AK.

Postgrad Med J. 2005 Mar;81(953):167-73. Review.

29.

Lactose causes heart arrhythmia in the water flea Daphnia pulex.

Campbell AK, Wann KT, Matthews SB.

Comp Biochem Physiol B Biochem Mol Biol. 2004 Oct;139(2):225-34.

PMID:
15465669
30.
31.

Escherichia coli lacking the AcrAB multidrug efflux pump also lacks nonproteinaceous, PHB-polyphosphate Ca2+ channels in the membrane.

Jones HE, Holland IB, Jacq A, Wall T, Campbell AK.

Biochim Biophys Acta. 2003 May 2;1612(1):90-7.

32.
33.

DNA damage-induced [Zn(2+)](i) transients: correlation with cell cycle arrest and apoptosis in lymphoma cells.

Smith PJ, Wiltshire M, Davies S, Chin SF, Campbell AK, Errington RJ.

Am J Physiol Cell Physiol. 2002 Aug;283(2):C609-22.

34.

[Validation of the use of aequorin for cytoplasmic free calcium determination by chemiluminescence in Streptococcus pneumoniae].

Chapuy-Regaud S, Jones HE, Campbell AK, Trombe MC.

J Soc Biol. 2001;195(3):271-6. French.

PMID:
11833464
35.

A mathematical model predicts that calreticulin interacts with the endoplasmic reticulum Ca(2+)-ATPase.

Baker HL, Errington RJ, Davies SC, Campbell AK.

Biophys J. 2002 Feb;82(2):582-90.

36.

Measurement of proteases using chemiluminescence-resonance-energy-transfer chimaeras between green fluorescent protein and aequorin.

Waud JP, Bermúdez Fajardo A, Sudhaharan T, Trimby AR, Jeffery J, Jones A, Campbell AK.

Biochem J. 2001 Aug 1;357(Pt 3):687-97.

37.

Phorbol ester-induced phosphoinositide hydrolysis in rat aorta: role of cyclooxygenase products.

Rapoport RM, Williams SP, Campbell AK.

Life Sci. 2000 Sep 1;67(15):1815-24.

PMID:
11043604
38.

Differential regulation of norepinephrine- and prostaglandin F2alpha-induced contraction by extracellular Na+ in rat aorta.

Rapoport RM, Campbell AK, Chang KC.

J Cardiovasc Pharmacol. 2000 Sep;36(3):288-96.

PMID:
10975584
39.

Chimeric green fluorescent protein-aequorin as bioluminescent Ca2+ reporters at the single-cell level.

Baubet V, Le Mouellic H, Campbell AK, Lucas-Meunier E, Fossier P, Brúlet P.

Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7260-5.

40.

Targeted bioluminescent indicators in living cells.

Sala-Newby GB, Badminton MN, Evans WH, George CH, Jones HE, Kendall JM, Ribeiro AR, Campbell AK.

Methods Enzymol. 2000;305:479-98. No abstract available.

PMID:
10812621
41.

When sugar is not so sweet.

Matthews SB, Campbell AK.

Lancet. 2000 Apr 15;355(9212):1330. No abstract available.

PMID:
10776747
42.

Cloning and expression of the bioluminescent photoprotein pholasin from the bivalve mollusc Pholas dactylus.

Dunstan SL, Sala-Newby GB, Fajardo AB, Taylor KM, Campbell AK.

J Biol Chem. 2000 Mar 31;275(13):9403-9.

43.

Apoaequorin monitors degradation of endoplasmic reticulum (ER) proteins initiated by loss of ER Ca(2+).

Jeffery J, Kendall JM, Campbell AK.

Biochem Biophys Res Commun. 2000 Feb 24;268(3):711-5.

PMID:
10679270
44.

An assessment of the role of intracellular free Ca2+ in E. coli.

Holland IB, Jones HE, Campbell AK, Jacq A.

Biochimie. 1999 Aug-Sep;81(8-9):901-7. Review.

PMID:
10572304
45.
46.

Role of calreticulin in regulating intracellular Ca2+ storage and capacitative Ca2+ entry in HeLa cells.

Llewelyn Roderick H, Llewellyn DH, Campbell AK, Kendall JM.

Cell Calcium. 1998 Oct;24(4):253-62.

PMID:
9883279
47.
48.

Imaging bioluminescent indicators shows Ca2+ and ATP permeability thresholds in live cells attacked by complement.

Sala-Newby GB, Taylor KM, Badminton MN, Rembold CM, Campbell AK.

Immunology. 1998 Apr;93(4):601-9.

49.

Current evidence suggests independent regulation of nuclear calcium.

Badminton MN, Kendall JM, Rembold CM, Campbell AK.

Cell Calcium. 1998 Feb-Mar;23(2-3):79-86. Review.

PMID:
9601602
50.

Assembly of chimeric connexin-aequorin proteins into functional gap junction channels. Reporting intracellular and plasma membrane calcium environments.

Martin PE, George CH, Castro C, Kendall JM, Capel J, Campbell AK, Revilla A, Barrio LC, Evans WH.

J Biol Chem. 1998 Jan 16;273(3):1719-26.

Supplemental Content

Loading ...
Support Center